Logo

Metabolic Disease

News on research and diagnostics for metabolic disorders and metabolic diseases.

Type 2 Diabetes Mechanisms, Risk Genes Identified in GWAS Meta-Analysis

Researchers uncovered candidate risk genes and potential mechanisms and conducted further analyses of proinsulin-associated risk loci.

Analysis Highlights Plasma Metabolites With Roles in Common Diseases

According to the researchers, these metabolites could potentially be targeted by drugs to manage disease.

Study Finds Metabolomic States Informing Common Disease Risk

After identifying disease-specific metabolomic states for 23 common conditions, researchers considered the predictive performance of the blood-based markers.

Australian Study to Assess Feasibility, Scalability of Population Genetics Screening
Premium

A pilot study will assess population screening for several highly penetrant disorders for inclusion in Australia's public healthcare system. 

Metabolon, University of Oxford Parkinson's Disease Centre Strike Research Partnership

The collaborators hope that understanding metabolic changes associated with Parkinson's will shed light on the disease.

Jun 30, 2022

PreventionGenetics Nabs FDA Approval for Obesity Drug Companion Diagnostic

Jun 30, 2022

MultiOmic Health, Mesh Bio Partner to Study Chronic Metabolic Disease for Drug, Dx Development

Jun 22, 2022

Metabolon, University of Maryland School of Medicine Partner for Amish Study 

Mar 14, 2022

Viome Life Sciences Prepares Clinical Study of Microbial Transcriptome Test in Oral, Throat Cancer
Premium

Feb 22, 2022

Genetic Technologies Lab Gets Regulatory Approvals in US, Australia

Feb 17, 2022

UK Biobank Exome Study Uncovers Rare Variants Contributing to Cardiometabolic Disease, Traits

Feb 14, 2022

Cardiometabolic Disease Shows Ties to Depressive Mood, Irrespective of Genetic Risk

Feb 10, 2022

FinnGen, Metabolon to Incorporate Metabolomics in Study of Finnish Population
Premium

Nov 3, 2021

GWAS Meta-Analysis Finds Five Genetic Loci Associated With Non-Alcoholic Fatty Liver Disease

Nov 1, 2021

SomaLogic Collaborating With UH Cleveland Medical Center on Use of SomaSignal Tests

Sep 15, 2021

Broad Institute, Novo Nordisk Foundation Launch Center to Study Genomic Mechanisms of Disease

Jul 12, 2021

Metabolomic Profiling Diagnoses Inborn Errors of Metabolism at Higher Rate Than Traditional Approach

Jul 7, 2021

Rare Mutations Associated With Significantly Higher Risk of Type 2 Diabetes in New Study

Jul 1, 2021

Rare Variants in G Protein-Coupled Receptor Gene May Provide Protection From Obesity

Apr 22, 2021

Renalytix AI Lands US Government Contract for Kidney Disease Test

Mar 17, 2021

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Feb 24, 2021

RenalytixAI Inks Deal to Introduce Kidney Function Testing Platform at University of Utah Health

Feb 11, 2021

Global, Local Polynesian Ancestry Influence Disease Risk Among Native Hawaiians

Dec 3, 2020

Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing

Oct 7, 2020

Patia Biopharma, Precision Diabetes to Collaborate on Diabetes Biomarker Development

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.